What does CUSIP Y95308105 represent in this 13F holders report?

CUSIP Y95308105 is the security identifier for WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value used to aggregate holder disclosures.

How many institutions held WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in Q2 2022?

56 institutional investors reported WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value for Q2 2022. Use the holders table for investor-level position and value details.

Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE)

CUSIP: Y95308105

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Ordinary Shares, no par value
Shares outstanding: 188,679,245
Total 13F shares: 67,784,074
Share change: +20,282,045
Total reported value: $220,297,785
Price per share: $3.25
Number of holders: 56
Value change: +$69,127,143
Number of buys: 21
Number of sells: 55

Quarterly Holders Quick Answers

What is CUSIP Y95308105?
CUSIP Y95308105 identifies WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP Y95308105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of WVE - Wave Life Sciences Ltd. - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
RA CAPITAL MANAGEMENT, L.P.	13F	Company	4.1%	7,775,207	$15,550,000	—	31 Mar 2022	13F
M28 Capital Management LP	13F	Company	3.1%	5,850,000	$11,700,000	—	31 Mar 2022	13F
MAVERICK CAPITAL LTD	13F	Company	3%	5,593,389	$11,187,000	—	31 Mar 2022	13F
Bellevue Group AG	13F	Company	2.4%	4,562,858	$9,126,000	—	31 Mar 2022	13F
PRIMECAP MANAGEMENT CO/CA/	13F	Company	2.4%	4,561,275	$9,123,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	1.6%	2,937,786	$5,876,000	—	31 Mar 2022	13F
Kynam Capital Management, LP	13F	Company	1%	1,911,728	$3,823,000	—	31 Mar 2022	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.71%	1,336,105	$2,672,000	—	31 Mar 2022	13F
D. E. Shaw & Co., Inc.	13F	Company	0.58%	1,091,300	$2,182,000	—	31 Mar 2022	13F
Ikarian Capital, LLC	13F	Company	0.56%	1,048,039	$2,095,000	—	31 Mar 2022	13F
Artal Group S.A.	13F	Company	0.53%	1,000,000	$2,000,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	0.48%	902,846	$1,806,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.47%	879,638	$1,759,000	—	31 Mar 2022	13F
Nantahala Capital Management, LLC	13F	Company	0.43%	819,101	$1,638,000	—	31 Mar 2022	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.41%	766,058	$1,532,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.4%	756,478	$1,512,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	0.37%	700,588	$1,401,000	—	31 Mar 2022	13F
SG Americas Securities, LLC	13F	Company	0.26%	486,048	$972,000	—	31 Mar 2022	13F
683 Capital Management, LLC	13F	Company	0.24%	462,047	$924,000	—	31 Mar 2022	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.24%	450,000	$900,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.22%	423,365	$847,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	421,412	$843,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.21%	391,546	$783,000	—	31 Mar 2022	13F
DAFNA Capital Management LLC	13F	Company	0.21%	390,161	$780,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.11%	205,194	$410,000	—	31 Mar 2022	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.1%	196,887	$394,000	—	31 Mar 2022	13F
Mirae Asset Global Investments Co., Ltd.	13F	Company	0.09%	169,432	$339,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.07%	139,637	$338,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.07%	127,110	$254,000	—	31 Mar 2022	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.06%	114,279	$229,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.06%	109,405	$220,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.05%	97,147	$195,000	—	31 Mar 2022	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.04%	84,660	$169,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.04%	81,955	$164,000	—	31 Mar 2022	13F
FRANKLIN RESOURCES INC	13F	Company	0.04%	68,059	$136,000	—	31 Mar 2022	13F
FMR LLC	13F	Company	0.04%	66,594	$133,000	—	31 Mar 2022	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.03%	56,544	$113,000	—	31 Mar 2022	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.02%	44,937	$90,000	—	31 Mar 2022	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.02%	43,152	$86,000	—	31 Mar 2022	13F
WS MANAGEMENT LLLP	13F	Company	0.02%	42,722	$85,000	—	31 Mar 2022	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.02%	40,886	$82,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.02%	40,249	$80,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.02%	33,900	$68,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.02%	29,982	$60,000	—	31 Mar 2022	13F
SEI INVESTMENTS CO	13F	Company	0.02%	29,000	$58,000	—	31 Mar 2022	13F
ALGERT GLOBAL LLC	13F	Company	0.01%	27,740	$55,000	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	25,133	$50,000	—	31 Mar 2022	13F
Gyon Technologies Capital Management, LP	13F	Company	0.01%	24,567	$49,000	—	31 Mar 2022	13F
AMERICAN INTERNATIONAL GROUP, INC.	13F	Company	0.01%	21,979	$44,000	—	31 Mar 2022	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.01%	21,953	$44,000	—	31 Mar 2022	13F

Institutional Holders of Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) as of Q2 2022

As of 30 Jun 2022, Wave Life Sciences Ltd. - Ordinary Shares, no par value (WVE) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 67,784,074 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., M28 Capital Management LP, MAVERICK CAPITAL LTD, 683 Capital Management, LLC, Bellevue Group AG, PRIMECAP MANAGEMENT CO/CA/, Artal Group S.A., ADAGE CAPITAL PARTNERS GP, L.L.C., Kynam Capital Management, LP, and BlackRock Inc.. This page lists 56 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

Q2 2022 holders

Holder diff

-21

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.